Skip to main content
Log in

Atenolol versus pindolol: Side-effects in hypertension

  • Short Communications
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

This randomized crossover out-patient study was designed to compare the antihypertensive effects of atenolol and pindolol. After a wash-out period of two weeks in pretreated cases, 107 patients with essential hypertension were given either atenolol 100 mg once-daily or pindolol 20 mg slow release (SR) once-daily. Both atenolol and pindolol lowered blood pressure over the 24 week period. The diastolic blood pressure reduction was significantly greater (p<0.01) with atenolol than with pindolol. Before β-blocker therapy, many patients had already experienced side-effects such as fatigue, sleep disturbances and dreams. This probably relates to the high sensitivity of the analogue scale used to assess side-effects, and to the high incidence of such symptoms in untreated patients. As the study progressed there was a reduction in the frequency of fatigue (p<0.03) and dreams (p<0.05) in both groups, whereas sleep disturbances significantly increased under pindolol (p<0.05) but decreased under atenolol (p<0.05). The only important side-effect difference between the two β-blockers was the higher incidence of sleep disturbances with pindolol which may be due to the higher lipophilicity of this β-blocker.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Cruickshank JM (1980) The clinical importance of cardioselectivity and lipophilicity in beta blockers. Am Heart J 100: 160–178

    Google Scholar 

  2. Frewin DB, Penhall RK, Leonello PP, Clapp RJ (1980) Atenolol in hypertension: follow up of patients crossed over to this agent from propranolol, pindolol or metoprolol. New Zealand Med J 92: 389–390

    Google Scholar 

  3. Frishman W (1979) Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 1. Pharmacodynamic and pharmacokinetic properties. Am Heart J 97: 663–670

    Google Scholar 

  4. Greminger P, Vetter H, Boerlin HJ, Havelka J, Baumgart P, Walger P, Lüscher T, Siegenthaler W, Vetter W (1983) A comparative study between 100 mg atenolol and 20 mg pindolol slow release in essential hypertension. Drugs 25 (Suppl. 2): 37–41

    Google Scholar 

  5. McNeil JJ, Louis WJ (1979) A double-blind crossover comparison of pindolol, metoprolol, atenolol and labetalol in mild hypertension. Br J Clin Pharmacol 8: 163S-166S

    Google Scholar 

  6. Waal-Manning HJ (1979) Atenolol and three non-selective beta-blockers in hypertension. Clin Pharmacol Ther 25: 8–18

    Google Scholar 

  7. Waal-Manning HJ, Simpson FO (1974) Pindolol: a comparison with other antihypertensive drugs and a double-blind placebo trial. New Zealand Med J 80: 151–155

    Google Scholar 

  8. Wilcox RG (1978) Randomized study of six beta-blockers and a thiazide diuretic in essential hypertension. Br Med J 2: 383–385

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Foerster, E.C., Greminger, P., Siegenthaler, W. et al. Atenolol versus pindolol: Side-effects in hypertension. Eur J Clin Pharmacol 28 (Suppl 1), 89–91 (1985). https://doi.org/10.1007/BF00543717

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00543717

Key words

Navigation